Ieq Capital LLC Has $2.61 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

Ieq Capital LLC reduced its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 8.8% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,703 shares of the company’s stock after selling 836 shares during the quarter. Ieq Capital LLC’s holdings in HCA Healthcare were worth $2,612,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the business. TBH Global Asset Management LLC grew its holdings in shares of HCA Healthcare by 1.2% in the 4th quarter. TBH Global Asset Management LLC now owns 7,081 shares of the company’s stock valued at $2,125,000 after acquiring an additional 83 shares in the last quarter. Private Advisor Group LLC increased its position in shares of HCA Healthcare by 28.7% during the 4th quarter. Private Advisor Group LLC now owns 4,354 shares of the company’s stock worth $1,307,000 after purchasing an additional 972 shares during the last quarter. Valley Wealth Managers Inc. boosted its holdings in shares of HCA Healthcare by 9.5% in the 4th quarter. Valley Wealth Managers Inc. now owns 1,515 shares of the company’s stock valued at $455,000 after buying an additional 132 shares during the last quarter. Atria Wealth Solutions Inc. raised its position in HCA Healthcare by 28.6% during the fourth quarter. Atria Wealth Solutions Inc. now owns 4,256 shares of the company’s stock worth $1,277,000 after acquiring an additional 946 shares in the last quarter. Finally, Truist Financial Corp grew its position in shares of HCA Healthcare by 2.6% in the 4th quarter. Truist Financial Corp now owns 307,753 shares of the company’s stock valued at $92,372,000 after acquiring an additional 7,890 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analyst Ratings Changes

HCA has been the subject of a number of research analyst reports. Oppenheimer lifted their price target on HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a report on Monday, October 28th. KeyCorp decreased their target price on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a report on Tuesday, January 7th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $405.00 price objective on shares of HCA Healthcare in a research report on Monday, January 27th. TD Cowen cut their target price on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research note on Monday, October 28th. Finally, Barclays cut their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $385.67.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the business’s stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the sale, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at $4,971,757.08. The trade was a 38.22 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Trading Down 1.7 %

Shares of HCA opened at $316.07 on Friday. The business’s fifty day moving average is $313.53 and its 200-day moving average is $350.83. The firm has a market cap of $78.49 billion, a price-to-earnings ratio of 14.39, a PEG ratio of 1.10 and a beta of 1.64. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter last year, the firm posted $5.90 EPS. Equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.91%. The ex-dividend date of this dividend is Monday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio is presently 13.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.